Quarterly ResultJul 16, 2026, 06:07 AM
UnitedHealth Group Q2 Rev $112B, Adj EPS $6.38; Raises FY26 Outlook
AI Summary
UnitedHealth Group reported strong second quarter 2026 results, with revenues reaching $112.0 billion and adjusted earnings of $6.38 per share. The company also raised its full-year 2026 adjusted earnings outlook to a range of $19.50 to $20.00 per share, reflecting improved performance and outlook. Key initiatives include reforms in prior approvals, pharmacy benefits, and investments in technology and community support, alongside increased share repurchases and cash flow from operations.
Key Highlights
- Q2 2026 Revenues: $112.0 billion, up from $111.6 billion in Q2 2025.
- Q2 2026 Earnings from Operations: $8.0 billion, up from $5.2 billion in Q2 2025.
- Q2 2026 Adjusted EPS: $6.38, up from $4.08 in Q2 2025.
- Updated Full Year 2026 Adjusted EPS Outlook: $19.50 to $20.00 per share (raised from >$17.75).
- UnitedHealthcare Q2 2026 Revenues: $86.0 billion; Operating Earnings: $3.9 billion.
- Optum Q2 2026 Revenues: $65.7 billion; Operating Earnings: $4.0 billion.
- Cash Flows from Operations: ~$24.0 billion for full year 2026 (raised from >$18.0 billion).
- Share Repurchase: At least $5.0 billion for full year 2026 (raised from ~$2.5 billion).
Price Impact
More from UNH